SHS Capital
Investor profile
Venture capital
SHS Capital has backed 8 European tech companies across 8 funding rounds between 2018 and 2025, joining rounds totalling €127M. Most active in Healthtech and Software. Data as of 4 Nov 2026.
Also recorded as: SHS Ventures
Deals
8
distinct rounds
Companies
8
backed
Active span
2018–2025
8 yrs
Total round €
€127M
sum of rounds joined
Deals by year
distinct rounds / yearSHS Capital — deals by year — interactive chart.
Data table
| SHS Capital — deals by year | |
|---|---|
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2025 | 1 |
Top sectors
by dealsSHS Capital — top sectors — interactive chart.
Data table
| SHS Capital — top sectors | |
|---|---|
| Healthtech | 7 |
| Software | 1 |
| Cybersecurity | 1 |
Stages
by dealsSHS Capital — stages — interactive chart.
Data table
| SHS Capital — stages | |
|---|---|
| Other | 6 |
| Series B | 2 |
Countries
by dealsSHS Capital — countries — interactive chart.
Data table
| SHS Capital — countries | |
|---|---|
| Germany | 2 |
| Netherlands | 2 |
| France | 1 |
| Norway | 1 |
| Slovenia | 1 |
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Andenes Ventures1
- Aurinvest1
- Brabant Development Agency (BOM)1
- Charles River Laboratories1
- Dolby Family Ventures1
- eCapital1
- EIC Fund1
- Eurazeo1
- High-Tech Gründerfonds (HTGF)1
- IBB Ventures1
- INKEF Capital1
- Innovation Industries1
- Invest-NL1
- Kurma Partners1
- Medice Arzneimittel1
- Panakès Partners1
- Rubio Impact Ventures1
- Sham1
- Stenshagen Invest1
- Technologiegründerfonds Sachsen (TGFS)1
- Think.Health1
- Thuja Capital1
- Turenne Capital1
- Verve Ventures1
- VNG Innovation1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Salvia BioElectronics | Netherlands | 1 | €53M |
| Dr.Dropin | Norway | 1 | €19M |
| MESI Medical | Slovenia | 1 | €18M |
| PathoQuest | France | 1 | €15M |
| Simulands | Switzerland | 1 | €10M |
| Selfapy | Germany | 1 | €7.0M |
| Incision | Netherlands | 1 | €5.0M |
| Rhebo | Germany | 1 | €0 |